Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
ASH vs BCPC
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
ASH vs BCPC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $2.50B | $5.17B |
| Revenue (TTM) | $1.81B | $1.06B |
| Net Income (TTM) | $-706M | $158M |
| Gross Margin | 28.6% | 36.3% |
| Operating Margin | -33.9% | 21.0% |
| Forward P/E | 14.5x | 31.2x |
| Total Debt | $1.57B | $192M |
| Cash & Equiv. | $215M | $75M |
ASH vs BCPC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ashland Inc. (ASH) | 100 | 81.3 | -18.7% |
| Balchem Corporation (BCPC) | 100 | 160.3 | +60.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ASH vs BCPC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ASH is the clearest fit if your priority is defensive.
- Beta 1.29, yield 3.0%, current ratio 2.85x
- Lower P/E (14.5x vs 31.2x)
- 3.0% yield, 7-year raise streak, vs BCPC's 0.5%
BCPC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 11 yrs, beta 0.33, yield 0.5%
- Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
- 162.8% 10Y total return vs ASH's 22.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.8% revenue growth vs ASH's -13.7% | |
| Value | Lower P/E (14.5x vs 31.2x) | |
| Quality / Margins | 15.0% margin vs ASH's -39.0% | |
| Stability / Safety | Beta 0.33 vs ASH's 1.29, lower leverage | |
| Dividends | 3.0% yield, 7-year raise streak, vs BCPC's 0.5% | |
| Momentum (1Y) | +16.8% vs BCPC's -0.8% | |
| Efficiency (ROA) | 9.4% ROA vs ASH's -15.5%, ROIC 12.2% vs -15.9% |
ASH vs BCPC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ASH vs BCPC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BCPC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ASH is the larger business by revenue, generating $1.8B annually — 1.7x BCPC's $1.1B. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to ASH's -39.0%. On growth, BCPC holds the edge at +8.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.8B | $1.1B |
| EBITDAEarnings before interest/tax | -$430M | $267M |
| Net IncomeAfter-tax profit | -$706M | $158M |
| Free Cash FlowCash after capex | $343M | $182M |
| Gross MarginGross profit ÷ Revenue | +28.6% | +36.3% |
| Operating MarginEBIT ÷ Revenue | -33.9% | +21.0% |
| Net MarginNet income ÷ Revenue | -39.0% | +15.0% |
| FCF MarginFCF ÷ Revenue | +19.0% | +17.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.6% | +8.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -46.2% | +10.6% |
Valuation Metrics
ASH leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.5B | $5.2B |
| Enterprise ValueMkt cap + debt − cash | $3.9B | $5.3B |
| Trailing P/EPrice ÷ TTM EPS | -2.97x | 33.97x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.51x | 31.23x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.65x |
| EV / EBITDAEnterprise value multiple | — | 20.06x |
| Price / SalesMarket cap ÷ Revenue | 1.37x | 4.98x |
| Price / BookPrice ÷ Book value/share | 1.32x | 4.18x |
| Price / FCFMarket cap ÷ FCF | — | 29.86x |
Profitability & Efficiency
BCPC leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
BCPC delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-38 for ASH. BCPC carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to ASH's 0.83x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs ASH's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -37.5% | +12.4% |
| ROA (TTM)Return on assets | -15.5% | +9.4% |
| ROICReturn on invested capital | -15.9% | +12.2% |
| ROCEReturn on capital employed | -16.6% | +14.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 9 |
| Debt / EquityFinancial leverage | 0.83x | 0.15x |
| Net DebtTotal debt minus cash | $1.4B | $117M |
| Cash & Equiv.Liquid assets | $215M | $75M |
| Total DebtShort + long-term debt | $1.6B | $192M |
| Interest CoverageEBIT ÷ Interest expense | -9.20x | 15.23x |
Total Returns (Dividends Reinvested)
BCPC leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BCPC five years ago would be worth $12,441 today (with dividends reinvested), compared to $7,012 for ASH. Over the past 12 months, ASH leads with a +16.8% total return vs BCPC's -0.8%. The 3-year compound annual growth rate (CAGR) favors BCPC at 8.6% vs ASH's -12.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -8.1% | +4.8% |
| 1-Year ReturnPast 12 months | +16.8% | -0.8% |
| 3-Year ReturnCumulative with dividends | -33.6% | +28.0% |
| 5-Year ReturnCumulative with dividends | -29.9% | +24.4% |
| 10-Year ReturnCumulative with dividends | +22.2% | +162.8% |
| CAGR (3Y)Annualised 3-year return | -12.8% | +8.6% |
Risk & Volatility
BCPC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BCPC is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than ASH's 1.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BCPC currently trades 87.8% from its 52-week high vs ASH's 83.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.29x | 0.33x |
| 52-Week HighHighest price in past year | $65.65 | $183.90 |
| 52-Week LowLowest price in past year | $46.30 | $139.17 |
| % of 52W HighCurrent price vs 52-week peak | +83.2% | +87.8% |
| RSI (14)Momentum oscillator 0–100 | 42.5 | 32.3 |
| Avg Volume (50D)Average daily shares traded | 690K | 189K |
Analyst Outlook
Evenly matched — ASH and BCPC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates ASH as "Buy" and BCPC as "Buy". Consensus price targets imply 22.7% upside for ASH (target: $67) vs 0.4% for BCPC (target: $162). For income investors, ASH offers the higher dividend yield at 3.03% vs BCPC's 0.54%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $67.00 | $162.00 |
| # AnalystsCovering analysts | 24 | 10 |
| Dividend YieldAnnual dividend ÷ price | +3.0% | +0.5% |
| Dividend StreakConsecutive years of raises | 7 | 11 |
| Dividend / ShareAnnual DPS | $1.65 | $0.87 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.0% | +2.1% |
BCPC leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ASH leads in 1 (Valuation Metrics). 1 tied.
ASH vs BCPC: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ASH or BCPC a better buy right now?
For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.
8% revenue growth year-over-year, versus -13. 7% for Ashland Inc. (ASH). Balchem Corporation (BCPC) offers the better valuation at 34. 0x trailing P/E (31. 2x forward), making it the more compelling value choice. Analysts rate Ashland Inc. (ASH) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ASH or BCPC?
On forward P/E, Ashland Inc.
is actually cheaper at 14. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — ASH or BCPC?
Over the past 5 years, Balchem Corporation (BCPC) delivered a total return of +24.
4%, compared to -29. 9% for Ashland Inc. (ASH). Over 10 years, the gap is even starker: BCPC returned +162. 8% versus ASH's +22. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ASH or BCPC?
By beta (market sensitivity over 5 years), Balchem Corporation (BCPC) is the lower-risk stock at 0.
33β versus Ashland Inc. 's 1. 29β — meaning ASH is approximately 290% more volatile than BCPC relative to the S&P 500. On balance sheet safety, Balchem Corporation (BCPC) carries a lower debt/equity ratio of 15% versus 83% for Ashland Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ASH or BCPC?
By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.
8% versus -13. 7% for Ashland Inc. (ASH). On earnings-per-share growth, the picture is similar: Balchem Corporation grew EPS 20. 9% year-over-year, compared to -643. 5% for Ashland Inc.. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ASH or BCPC?
Balchem Corporation (BCPC) is the more profitable company, earning 14.
9% net margin versus -46. 3% for Ashland Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus -42. 5% for ASH. At the gross margin level — before operating expenses — BCPC leads at 35. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ASH or BCPC more undervalued right now?
On forward earnings alone, Ashland Inc.
(ASH) trades at 14. 5x forward P/E versus 31. 2x for Balchem Corporation — 16. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ASH: 22. 7% to $67. 00.
08Which pays a better dividend — ASH or BCPC?
All stocks in this comparison pay dividends.
Ashland Inc. (ASH) offers the highest yield at 3. 0%, versus 0. 5% for Balchem Corporation (BCPC).
09Is ASH or BCPC better for a retirement portfolio?
For long-horizon retirement investors, Balchem Corporation (BCPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
33), 0. 5% yield, +162. 8% 10Y return). Both have compounded well over 10 years (BCPC: +162. 8%, ASH: +22. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ASH and BCPC?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ASH is a small-cap income-oriented stock; BCPC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.